Markets.com Logo

IBRX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    2.2136$
  • Previous Close
    2.2379$
  • 52 Week Change
    5.65$
  • Day Range
    -0.02$
  • 52 Week High/Low
    1.83$ - 7.48$
  • Dividend Per Share
    --
  • Market cap
    2 136 M$
  • EPS
    -0.1
  • Beta
    -0.068
  • Volume
    --

About

IBRX.US refers to ImmunityBio Inc. stock traded on the Nasdaq stock exchange. ImmunityBio is a late-stage immunotherapy company developing targeted natural killer (NK) and T-cell cancer immunotherapies and vaccines that activate both the innate (natural killer cell) and adaptive (T-cell) immune systems to treat cancers and infectious diseases.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Clinical Trial Results: Positive or negative data from IBRX's clinical trials significantly impacts investor confidence and stock valuation.

Regulatory Approvals: FDA approval or rejection of IBRX's drug candidates directly influences the potential revenue and market share, thus affecting the stock price.

Competition: The presence of competing drugs or therapies can erode IBRX's market share and potential profitability, impacting its stock value.

Market Sentiment: Overall investor sentiment towards the biotechnology sector and the broader market can affect IBRX's stock price, regardless of company-specific news.

Financial Performance: IBRX's revenue, earnings, and cash flow can indicate the company's financial health and growth potential, influencing investor decisions.

Partnerships and Acquisitions: Collaborations with other pharmaceutical companies or potential acquisition targets can generate excitement and speculation, affecting the stock price.

News and Events: Company-specific news, such as leadership changes, strategic announcements, or unexpected setbacks, can create volatility in IBRX's stock price.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--